FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions
For Immediate Release: January 06, 2025 Today, the U.S. Food and Drug Administration issued draft guidance to provide recommendations on the use of artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product’s …